Medtech employment remained steady in last year with most medical device makers experiencing an increase in their workforce, according to a new jobs report published by EP Vantage.
Medtech employment remained steady in last year with most medical device makers experiencing an increase in their workforce, according to a new jobs report published by EP Vantage.
Of the top 15 device makers, only three experienced a reduction in headcount and two of those were due to companies spinning off their respective pharmaceutical operations, the report shows. Otherwise the top 15 largest medtech firms managed to grow their workforces by an average of 6 percent.
Companies including Baxter International and Stryker grew through multibillion-dollar acquisitions of other medtech companies. Baxter was the fastest growing among the top 15 companies in 2013 thanks in part to its acquisition of Gambro, which added 10,000 employees for a growth rate of 20 percent.
“[With] several megamergers underway, we can expect to see much more drastic changes in device makers’ headcounts in the coming years,”commented Elizabeth Cairns, the report’s author.
However, acquisitions did not play a role for the number two-ranked hirer, Intuitive Surgical. Despite a tumultuous year, the firm brought on 28 new salespeople in 2013, an increase of 30 percent.
For more on the report report, visit www.evaluategroup.com/MedtechJobNumbers
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
Applying Porter’s Five Forces to Portfolio Management in Pharmaceutical R&D: A Strategic Roadmap
March 17th 2025The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic portfolio management to optimize resource allocation and enhance competitive advantage.